InvestorsHub Logo
Followers 2
Posts 164
Boards Moderated 0
Alias Born 01/26/2010

Re: ubet post# 7747

Thursday, 03/17/2011 6:07:03 PM

Thursday, March 17, 2011 6:07:03 PM

Post# of 64403
Teva's proprietary research and development pipeline is currently focused primarily on three niche specialty areas: neurological disorders, autoimmune diseases and oncology. Currently there are several innovative products in advanced development stages for the treatment of Multiple sclerosis, Crohn's disease , ALS and more.

Just RUMORS yet!!!!!!!